Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Bull Market and Beyond: 2 Stocks to Buy and Hold Forever
Bull Market and Beyond: 2 Stocks to Buy and Hold Forever

Investors are enjoying the ongoing bull run. The S&P 500 and Nasdaq Composite recently hit all-time highs. Though that's pretty exciting, bull markets don't last forever. Equities that can perform

EQS-Adhoc: STRATEC PLANS TO DISTRIBUTE DIVIDEND OF € 0.55 PER SHARE FOR 2023 FINANCIAL YEAR
EQS-Adhoc: STRATEC PLANS TO DISTRIBUTE DIVIDEND OF € 0.55 PER SHARE FOR 2023 FINANCIAL YEAR
EQS-Adhoc: STRATEC PLANS TO DISTRIBUTE DIVIDEND OF € 0.55 PER SHARE FOR 2023 FINANCIAL YEAR
Humana and DUOS Launch Groundbreaking Initiative Enhancing Care for U.S. Veteran Seniors
Humana and DUOS Launch Groundbreaking Initiative Enhancing Care for U.S. Veteran Seniors


Humana Inc. (NYSE: HUM) and DUOS, a technology-enabled service provider announces a new collaborative program to enhance the healthcare experience and improve health outcomes for Louisiana Veteran

STAAR Surgical Celebrates Three Million Implantable Collamer® Lenses
STAAR Surgical Celebrates Three Million Implantable Collamer® Lenses


STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today

2 Medical Device Stocks to Buy Hand Over Fist in March
2 Medical Device Stocks to Buy Hand Over Fist in March

A good way to invest in the healthcare industry's continued growth is by targeting businesses that make medical devices. Such equipment aids physicians in surgery, helps patients recover, and can

2 Medical Device Stocks to Buy Hand Over Fist in March
2 Medical Device Stocks to Buy Hand Over Fist in March

A good way to invest in the healthcare industry's continued growth is by targeting businesses that make medical devices. Such equipment aids physicians in surgery, helps patients recover, and can

Why Victoria's Secret Stock Plummeted Today
Why Victoria's Secret Stock Plummeted Today

Shares of Victoria's Secret (NYSE: VSCO) plummeted 29.7% on Thursday after the lingerie, clothing, and beauty-products retailer announced reasonably solid quarterly results but followed with

Stelo by Dexcom First Glucose Biosensor to be Cleared by FDA as Over-the-Counter
Stelo by Dexcom First Glucose Biosensor to be Cleared by FDA as Over-the-Counter


DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that the FDA has cleared Stelo by Dexcom – the first glucose

Stelo by Dexcom First Glucose Biosensor to be Cleared by FDA as Over-the-Counter
Stelo by Dexcom First Glucose Biosensor to be Cleared by FDA as Over-the-Counter


DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that the FDA has cleared Stelo by Dexcom – the first glucose

3 High-Yield S&P 500 Dividend Stocks Down More Than 28% to Buy Now and Hold at Least a Decade
3 High-Yield S&P 500 Dividend Stocks Down More Than 28% to Buy Now and Hold at Least a Decade

Rising tides don't always lift all boats. The S&P 500 index reached new all-time highs several times since 2024 began, but many of its components have not participated in the rally.

With most

Dexcom Showcases Leadership in AID and Power of Dexcom CGM in Type 2 Diabetes With New Data at ATTD
Dexcom Showcases Leadership in AID and Power of Dexcom CGM in Type 2 Diabetes With New Data at ATTD


DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, announced compelling new clinical evidence supporting the use of Dexcom

Dexcom Showcases Leadership in AID and Power of Dexcom CGM in Type 2 Diabetes With New Data at ATTD
Dexcom Showcases Leadership in AID and Power of Dexcom CGM in Type 2 Diabetes With New Data at ATTD


DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, announced compelling new clinical evidence supporting the use of Dexcom

Why Illumina Stock Mashed the Market on Monday
Why Illumina Stock Mashed the Market on Monday

Gene-sequencing stock Illumina (NASDAQ: ILMN) was a standout in the biotech sector Monday, with its share-price rise convincingly beating the S&P 500 index. Investors were cheered by a stock buy

Why Illumina Stock Mashed the Market on Monday
Why Illumina Stock Mashed the Market on Monday

Gene-sequencing stock Illumina (NASDAQ: ILMN) was a standout in the biotech sector Monday, with its share-price rise convincingly beating the S&P 500 index. Investors were cheered by a stock buy

Why Illumina Stock Mashed the Market on Monday
Why Illumina Stock Mashed the Market on Monday

Gene-sequencing stock Illumina (NASDAQ: ILMN) was a standout in the biotech sector Monday, with its share-price rise convincingly beating the S&P 500 index. Investors were cheered by a stock buy

If You Invested $10,000 in Medtronic in 2019, This Is How Much You Would Have Today
If You Invested $10,000 in Medtronic in 2019, This Is How Much You Would Have Today

For seasoned healthcare investors, Medtronic (NYSE: MDT) needs no introduction. The medical device specialist has been around for decades, successfully navigating one of the most highly regulated

Could Eli Lilly Stock Help You Become a Millionaire?
Could Eli Lilly Stock Help You Become a Millionaire?

Eli Lilly (NYSE: LLY) has been on a tear this past year, rising up to become the most valuable healthcare stock in the world. It soared past UnitedHealth Group and other top healthcare companies in

Could Eli Lilly Stock Help You Become a Millionaire?
Could Eli Lilly Stock Help You Become a Millionaire?

Eli Lilly (NYSE: LLY) has been on a tear this past year, rising up to become the most valuable healthcare stock in the world. It soared past UnitedHealth Group and other top healthcare companies in

Where Will Medtronic Stock Be in 3 Years?
Where Will Medtronic Stock Be in 3 Years?

Medtronic (NYSE: MDT) is a leading medical device company that aims to simplify patients' everyday lives. And with a broad presence that spans 150 countries, treating more than 70 health conditions

EQS-News: Gerresheimer decisively continues on profitable growth course in financial year 2023
EQS-News: Gerresheimer decisively continues on profitable growth course in financial year 2023
EQS-News: Gerresheimer decisively continues on profitable growth course in financial year 2023
Is Medtronic Stock a Buy Now?
Is Medtronic Stock a Buy Now?

Every long-term investor should have at least some healthcare stocks in their portfolio. People will always need care, and the industry constantly looks for new and better ways to provide it

QuidelOrtho Announces Changes in Executive Leadership
QuidelOrtho Announces Changes in Executive Leadership


The Board of Directors (the “Board”) of QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”) has made significant decisions aimed to enhance operational efficiency, drive revenue

Why Medtronic Stock Jumped Today
Why Medtronic Stock Jumped Today

Shares of Medtronic (NYSE: MDT) climbed as much as 3.3% early Tuesday, and then settled to close up around 1.7%, after the medical-device company announced strong fiscal third-quarter results and

Henry Ford Health and Acadia Healthcare Appoint Emily Sexton as CEO of New Henry Ford Behavioral Health Hospital
Henry Ford Health and Acadia Healthcare Appoint Emily Sexton as CEO of New Henry Ford Behavioral Health Hospital


Henry Ford Health, one of the nation’s premier academic and integrated health systems, and Acadia Healthcare, the nation’s largest stand-alone behavioral healthcare company, today announced the

Medtronic (MDT) Q3 2024 Earnings Call Transcript
Medtronic (MDT) Q3 2024 Earnings Call Transcript

Image source: The Motley Fool.

Medtronic (NYSE: MDT)Q3 2024 Earnings CallFeb 20, 2024, 8:00 a.m. ET

Ryan Weispfenning

Continue reading

Source Fool.com